Apr 6, 2023
In this episode, host Shikha Jain, MD, speaks
with Jorge García, PharmD, about the economic
benefits of biosimilars, the unique perspective pharmacists can
bring to cancer care costs and more.
• Welcome to another exciting episode of Oncology
Overdrive :14
• About García :23
• The interview 2:44
• How did you enter the world of pharmacy? What was
your journey into this field? 3:11
• Can you tell us about what biosimilars are, and how
you found yourself in this space?
5:09
• What do you think is the next step for biosimilars?
6:34
• What types of diseases specifically are biosimilars
the most exciting for? … What are diseases that biosimilars have
the highest impact in? 8:09
• What is Act4Biosimilars, and what do they do?
12:05
• How did you get involved with Act4Biosimilars?
13:04
• Can you expand on what Act4Biosimilars is doing to
address inequities and disparities in health care? Is there a way
to get biosimilars into the hands of more people who really need
it? 14:55
• How do you see the impact of these initiatives and
interventions are going to be over the next few years?
17:14
• How do you suggest people who are interested in
getting involved in this type of work find this path?
19:31
• Jain and García on his unique perspective of being a
pharmacist and having an MBA and understanding cost of care
24:22
• If you had a crystal ball, and you could see five or
ten years from now, what do you hope will have changed in the
biosimilar news space? 27:13
• If someone could only listen to the two minutes of
this episode, what would you want them to take away?
30:36
• How to contact García
31:27
• Thanks for listening
32:32
Jorge García, PharmD, MS, MHA, MBA, FACHE is the
assistant vice president at Baptist Health South Florida, where he
is responsible for oncology pharmacy services, non-oncology
infusion pharmacy services, and sterile compounding quality.
We’d love to hear from you! Send your comments/questions to Dr.
Jain at oncologyoverdrive@healio.com. Follow us on Twitter
@HemOncToday and @ShikhaJainMD. García can be reached via
LinkedIn.
Disclosures: García and Jain report no relevant
financial disclosures.